Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 348

1.

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY.

BMC Cancer. 2012 Oct 5;12:452. doi: 10.1186/1471-2407-12-452.

PMID:
23039099
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.

Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Albertini A, Fasola M, Boffetta P, Nardi G.

Int J Cancer. 1999 May 31;81(5):695-9.

PMID:
10328218
[PubMed - indexed for MEDLINE]
3.

Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.

Br├ęchot C, Jaffredo F, Lagorce D, Gerken G, Meyer zum B├╝schenfelde K, Papakonstontinou A, Hadziyannis S, Romeo R, Colombo M, Rodes J, Bruix J, Williams R, Naoumov N.

J Hepatol. 1998 Aug;29(2):173-83. Erratum in: J Hepatol 1998 Oct;29(4):686.

PMID:
9722197
[PubMed - indexed for MEDLINE]
4.

HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.

Lee DS, Huh K, Lee EH, Lee DH, Hong KS, Sung YC.

J Gastroenterol Hepatol. 1997 Dec;12(12):855-61.

PMID:
9504897
[PubMed - indexed for MEDLINE]
5.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
[PubMed - indexed for MEDLINE]
6.

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.

Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ; REVEAL-HBV Study Group.

J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43. doi: 10.1093/jnci/djn243. Epub 2008 Aug 11.

PMID:
18695135
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.

Suga M, Senota A, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, Sugai S, Yachi A.

Hepatogastroenterology. 1994 Oct;41(5):438-41.

PMID:
7531667
[PubMed - indexed for MEDLINE]
8.

Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.

Edamoto Y, Tani M, Kurata T, Abe K.

Cancer. 1996 May 1;77(9):1787-91.

PMID:
8646675
[PubMed - indexed for MEDLINE]
9.

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.

Donato F, Boffetta P, Puoti M.

Int J Cancer. 1998 Jan 30;75(3):347-54.

PMID:
9455792
[PubMed - indexed for MEDLINE]
10.

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.

Cancer. 1999 May 15;85(10):2132-7.

PMID:
10326690
[PubMed - indexed for MEDLINE]
11.
12.

Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.

Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ.

Cancer Epidemiol Biomarkers Prev. 1996 Mar;5(3):173-8.

PMID:
8833617
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.

Cancer. 1997 Dec 1;80(11):2060-7.

PMID:
9392327
[PubMed - indexed for MEDLINE]
15.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
[PubMed - indexed for MEDLINE]
Free Article
16.

Etiological and molecular profile of hepatocellular cancer from India.

Asim M, Sarma MP, Kar P.

Int J Cancer. 2013 Jul 15;133(2):437-45. doi: 10.1002/ijc.27993. Epub 2013 Feb 13.

PMID:
23233429
[PubMed - indexed for MEDLINE]
17.

Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.

Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, L'Italien G, Chen CJ, Yuan Y; REVEAL-HCV Study Group.

Int J Cancer. 2014 Sep 1;135(5):1119-26. doi: 10.1002/ijc.28753. Epub 2014 Feb 14.

PMID:
24482200
[PubMed - indexed for MEDLINE]
18.

Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.

Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH.

J Clin Gastroenterol. 1994 Oct;19(3):222-6.

PMID:
7528758
[PubMed - indexed for MEDLINE]
19.

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.

Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E; European Concerted Action on Viral Hepatitis (EUROHEP).

Am J Gastroenterol. 2002 Nov;97(11):2886-95.

PMID:
12425564
[PubMed - indexed for MEDLINE]
20.

Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.

Vaiphei K, Pal NS, Arora SK.

Indian J Pathol Microbiol. 2006 Jul;49(3):357-61.

PMID:
17001884
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk